产品标题 产品货号 产品规格 厂家
Stearoyl-CoA desaturase 5 (SCD5), transcript variant 2 from ORIGENE TECHNOLOGIESLY411005100 ugORIGENE TECHNOLOGIES
STE20-related kinase adaptor alpha (STRADA), transcript variant 4 from ORIGENE TECHNOLOGIESLY424003100 ugORIGENE TECHNOLOGIES
STE20-related kinase adaptor alpha (STRADA), transcript variant 6 from ORIGENE TECHNOLOGIESLY431260100 ugORIGENE TECHNOLOGIES
STE20-related kinase adaptor alpha (STRADA), transcript variant 3 from ORIGENE TECHNOLOGIESLY407054100 ugORIGENE TECHNOLOGIES
STE20-related kinase adaptor alpha (STRADA), transcript variant 5 from ORIGENE TECHNOLOGIESLY431276100 ugORIGENE TECHNOLOGIES
STE20-related kinase adaptor beta (STRADB) from ORIGENE TECHNOLOGIESLY402696100 ugORIGENE TECHNOLOGIES
Sterile alpha motif and leucine zipper containing kinase AZK (ZAK), transcript variant 1 from ORIGENE TECHNOLOGIESLY413852100 ugORIGENE TECHNOLOGIES
Sterile alpha motif and leucine zipper containing kinase AZK (ZAK), transcript variant 1 from ORIGENE TECHNOLOGIESLY429511100 ugORIGENE TECHNOLOGIES
Sterile alpha motif and leucine zipper containing kinase AZK (ZAK), transcript variant 2 from ORIGENE TECHNOLOGIESLY408752100 ugORIGENE TECHNOLOGIES
Sterile alpha motif domain containing 4A (SAMD4A), transcript variant 1 from ORIGENE TECHNOLOGIESLY414440100 ugORIGENE TECHNOLOGIES
Sterile alpha motif domain containing 4B (SAMD4B) from ORIGENE TECHNOLOGIESLY413368100 ugORIGENE TECHNOLOGIES
Sterile alpha motif domain containing 4A (SAMD4A), transcript variant 3 from ORIGENE TECHNOLOGIESLY431303100 ugORIGENE TECHNOLOGIES
Human Lymph node; Tumor, dendritic cell, follicular from ORIGENE TECHNOLOGIESCS6003005x5umORIGENE TECHNOLOGIES
Human Lymph node; Tumor, dendritic cell, follicular from ORIGENE TECHNOLOGIESCS6003015x5umORIGENE TECHNOLOGIES
Human lymphocyte-activation gene 3 (LAG3) from ORIGENE TECHNOLOGIESTP70022120 ugORIGENE TECHNOLOGIES
Human lymphocyte antigen 6 complex, locus H (LY6H), transcript variant 1 from ORIGENE TECHNOLOGIESTP30513620 ugORIGENE TECHNOLOGIES
Human lymphocyte-activation gene 3 (LAG3) from ORIGENE TECHNOLOGIESTP70022020 ugORIGENE TECHNOLOGIES
Human lymphocyte antigen 6 complex, locus G6F (LY6G6F) from ORIGENE TECHNOLOGIESTP31706720 ugORIGENE TECHNOLOGIES
Human lymphocyte antigen 86 (LY86) from ORIGENE TECHNOLOGIESTP30791320 ugORIGENE TECHNOLOGIES
Human lymphocyte antigen 6 complex, locus K (LY6K) from ORIGENE TECHNOLOGIESTP31249820 ugORIGENE TECHNOLOGIES
Human lymphocyte antigen 96 (LY96) from ORIGENE TECHNOLOGIESTP30468620 ugORIGENE TECHNOLOGIES
Human lymphocyte antigen 9 (LY9), transcript variant 1 from ORIGENE TECHNOLOGIESTP31820120 ugORIGENE TECHNOLOGIES
Human lymphocyte antigen 96 (LY96), transcript variant 2. from ORIGENE TECHNOLOGIESTP33096820 ugORIGENE TECHNOLOGIES
Human lymphocyte antigen 9 (LY9), transcript variant 1, residues 48-454aa, secretory expressed with GP67 signal peptide from ORIGENE TECHNOLOGIESTP71023820 ugORIGENE TECHNOLOGIES
Human lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) (LCP2) from ORIGENE TECHNOLOGIESTP30440420 ugORIGENE TECHNOLOGIES
Human lymphocyte cytosolic protein 1 (L-plastin) (LCP1) from ORIGENE TECHNOLOGIESTP30167020 ugORIGENE TECHNOLOGIES
Human lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) (LCP2) from ORIGENE TECHNOLOGIESTP72120110 ugORIGENE TECHNOLOGIES
Human lymphocyte-specific protein 1 (LSP1), transcript variant 1 from ORIGENE TECHNOLOGIESTP30071220 ugORIGENE TECHNOLOGIES
Human lymphocyte-specific protein tyrosine kinase (LCK), transcript variant 2 from ORIGENE TECHNOLOGIESTP31937520 ugORIGENE TECHNOLOGIES
Human Lymphoid tissue; Leukemia, hairy cell from ORIGENE TECHNOLOGIESCS5229085x5umORIGENE TECHNOLOGIES
Human Lymphoid tissue; Leukemia, hairy cell from ORIGENE TECHNOLOGIESCS5508205x5umORIGENE TECHNOLOGIES
Human lymphoid enhancer-binding factor 1 (LEF1), full length from ORIGENE TECHNOLOGIESTP76017750 ugORIGENE TECHNOLOGIES
Human Lymphoid tissue; Leukemia, lymphocytic, chronic from ORIGENE TECHNOLOGIESCS8028725x5umORIGENE TECHNOLOGIES
Human Lymphoid tissue; Leukemia, lymphocytic, chronic from ORIGENE TECHNOLOGIESCS8028735x5umORIGENE TECHNOLOGIES
Human Lymphoid tissue; Leukemia, lymphocytic, chronic from ORIGENE TECHNOLOGIESCS8028745x5umORIGENE TECHNOLOGIES
Human Lymphoid tissue; Leukemia, lymphocytic, chronic from ORIGENE TECHNOLOGIESCS8028765x5umORIGENE TECHNOLOGIES
Human Lymphoid tissue; Leukemia, lymphocytic, chronic from ORIGENE TECHNOLOGIESCS8028755x5umORIGENE TECHNOLOGIES
Gm6880 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5069771 kitORIGENE TECHNOLOGIES
Gm6890 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5069781 kitORIGENE TECHNOLOGIES
Gm7030 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5069821 kitORIGENE TECHNOLOGIES
Gm694 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5069811 kitORIGENE TECHNOLOGIES
Gm7073 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5069831 kitORIGENE TECHNOLOGIES
Gm6904 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5069791 kitORIGENE TECHNOLOGIES
Gm7120 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5069861 kitORIGENE TECHNOLOGIES
Gm7102 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5069841 kitORIGENE TECHNOLOGIES
Gm7173 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5069881 kitORIGENE TECHNOLOGIES
Gm7257 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5069901 kitORIGENE TECHNOLOGIES
Gm7244 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5069891 kitORIGENE TECHNOLOGIES
Gm732 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5069911 kitORIGENE TECHNOLOGIES
Gm7168 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5069871 kitORIGENE TECHNOLOGIES
 |< < 1261 1262 1263 1264 1265 1266 1267 1268 1269 > >| 第 1267/6274 页